Breaking news

Gender Equality Remains A Top Priority, Says Cypriot President

Gender equality remains a core priority for the Government, President Nikos Christodoulides stated on Wednesday during the presentation of the Commissioner for Gender Equality Josie Christodoulou’s report for March–December 2023.

Highlighting the Government’s commitment, President Christodoulides remarked, “There is still much work ahead, but we are encouraged by the progress we’re seeing. It is precisely these results that compel us to continue.” He emphasized that the report’s findings would be thoroughly examined by the Secretariat for Monitoring the Government’s Work to identify obstacles and inefficiencies, ensuring they are addressed in the 2025 annual planning.

Commissioner Christodoulou underscored the Government’s integrated approach, noting that policies promoting work-life balance, the increasing number of women in the Council of Ministers, education reforms, and comprehensive measures to combat violence against women are accelerating progress toward true gender equality. She also informed the President that Cyprus had climbed to 20th place in the European Institute for Gender Equality rankings this year.

“By integrating gender considerations across all Ministries and Deputy Ministries, we are advancing toward substantive equality between women and men,” Christodoulou said while acknowledging that significant challenges remain.

Deputy Minister to the President, Irene Piki, also attended the meeting, reflecting the Government’s united front on gender equality.

A Broader Perspective

While Cyprus doubles down on its commitment to gender equality, the global narrative presents a contrasting picture. In recent months, some companies and institutions have shifted away from Diversity, Equity, and Inclusion (DEI) initiatives, citing either a re-evaluation of priorities or criticism of their efficacy. Cyprus’ steadfast focus on equality amidst this backdrop serves as a reminder that achieving substantial change requires persistence, adaptability, and a clear vision—values that remain at the heart of the Christodoulides administration’s policies.

Medochemie And Theramir Announce Strategic Investment Agreement To Advance Biotech Manufacturing In Cyprus

Pharmaceutical manufacturer Medochemie and biotechnology company Theramir, both Cyprus-based, have announced a strategic investment agreement and collaboration aimed at developing next-generation biological therapies and expanding manufacturing capabilities in Cyprus.

The agreement, announced on 2 September 2026, brings together Medochemie’s experience in pharmaceutical manufacturing and Theramir’s biotechnology research. The companies said the collaboration would support advanced pharmaceutical manufacturing in Cyprus and south-eastern Europe.

What The Partnership Covers

Medochemie’s contribution will include its expertise in manufacturing sterile therapeutic products and its access to international markets.

Theramir develops technologies based on extracellular vesicles and microRNAs. Its work includes using stem-cell-derived extracellular vesicles to deliver microRNAs, small, non-coding RNA molecules that regulate genes and biological pathways associated with cancer growth and metastasis.

Under the agreement, the companies will jointly support the development of “Good Manufacturing Practice” capabilities for next-generation biological therapies. The partnership is also intended to help move these therapies towards clinical development.

A Wider Role For Cyprus

The collaboration will also support Theramir’s wider research programme. According to the companies, it is intended to strengthen Cyprus’s biotechnology infrastructure and expand local capacity in next-generation biomanufacturing.

They present the agreement as a step towards giving Cyprus a larger role in biotechnology and advanced pharmaceutical manufacturing for south-eastern Europe and international markets.

Aretilaw firm
The Future Forbes Realty Global Properties
Uol
eCredo

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter